Facet Biotech is a biotechnology company dedicated to advancing its pipeline of five clinical-stage products focused in multiple sclerosis and oncology, leveraging its research and development capabilities to identify and develop new oncology drugs and applying its proprietary next-generation protein engineering technologies to potentially improve the clinical performance of protein therapeutics.
Facet Biotech was acquired by Abbott Laboratories on March 09, 2010.
Join Mergr to view all 132 acquisitions of life science companies in 2010, including 17 acquisitions by private equity firms, and 115 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2010. The largest life science acquisition in 2010 was Solvay Pharmaceuticals - which was acquired by Abbott Laboratories for $6.1B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Facet Biotech.
No obligation. Cancel anytime.